No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SLNO240517C50000
- 0.33
- 0.000.00%
15min DelayTrading May 17 11:25 ET
0.00High0.00Low
0.00Open0.33Pre Close0 Volume0 Open Interest50.00Strike Price0.00Turnover990.51%IV19.29%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.33Time Value100Contract SizeAmericanOptions Type0.1714Delta0.0682Gamma127.85Leverage Ratio-19.5292Theta0.0000Rho21.91Eff Leverage0.0010Vega
Intraday
- 5D
- 1D
News
Piper Sandler Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $93
Piper Sandler analyst Yasmeen Rahimi maintains $Soleno Therapeutics(SLNO.US)$ with a buy rating, and maintains the target price at $93.According to TipRanks data, the analyst has a success rate of 35.
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Soleno Therapeutics (SLNO)
Soleno Therapeutics Announces Oral Presentation Featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
Soleno Therapeutics, Inc. (NASDAQ: SLNO) today announced that data from the randomized withdrawal period of Study C602 of DCCR (diazoxide choline) extended-release tablets in Prader-Willi Syndrome (PWS) will be featured in an oral presentation at the Annual Meeting of the Endocrine Society (ENDO 2024), being held June 1-4, 2024 in Boston, Massachusetts.
Soleno Therapeutics to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases,
Soleno Therapeutics Stands With the Prader-Willi Syndrome Community
This Prader-Willi Syndrome Awareness Day, May 15, join Soleno Therapeutics in sharing messages of hope and kindness for the Prader-Willi syndrome communityREDWOOD CITY, Calif., May 15, 2024 (GLOBE N
Soleno Therapeutics Is Maintained at Outperform by Oppenheimer
Soleno Therapeutics Is Maintained at Outperform by Oppenheimer
Comments
» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
5
Despite the increase in cash burn, the company's solid cash runway and the analysts' forecast of reaching breakeven point suggest a positive outlook. The company's cash burn relative to its market capitalisation, which is US$1.4b, is about 1.7%, indicating that it could potentially raise more cash easily if needed.
From small cap to big cap, it is interesting.
Now they have a way to treat diabetes, obesity. I believe later they will find a way to cure cancer, Alzheimer and other disease not just treat it and prevent it.
To clone something is unreal before, even travel to mars is real now. ( $Virgin Galactic(SPCE.US$
thank you for wonderful run $Tempest Therapeutics(TPST.US$ $Soleno Therapeutics(SLNO.US$ $Arcutis Biotherapeutics(ARQT.US$ $2seventy bio(TSVT.US$ $Redhill Biopharma(RDHL.US$ etc... th...
Now they have a way to treat diabetes, obesity. I believe later they will find a way to cure cancer, Alzheimer and other disease not just treat it and prevent it.
To clone something is unreal before, even travel to mars is real now. ( $Virgin Galactic(SPCE.US$
thank you for wonderful run $Tempest Therapeutics(TPST.US$ $Soleno Therapeutics(SLNO.US$ $Arcutis Biotherapeutics(ARQT.US$ $2seventy bio(TSVT.US$ $Redhill Biopharma(RDHL.US$ etc... th...
4
Is it Nvidia, the maker of chips related to artificial intelligence? This is despite the fact that the stock has soared more than 200% this year. Other big tech stocks like Apple are up nearly 50% this year, Microsoft is up about 56%, Google parent Alphabet's Class A and Class C shares are up nearly 60% each, Amazon is up more than 80%, Tesla has doubled more than doubled, and Meta almost tripled.
However, none of these stoc...
However, none of these stoc...
4
Read more